Prime Medicine, Inc.PRMENASDAQ
Loading
Cost of Revenue Over TimeStrong
Percentile Rank100
5Y CAGR+74.1%
Studio
Year-over-Year Change

Direct costs attributable to producing goods sold

5Y CAGR
+74.1%/yr
Long-term compound
Percentile
P100
Near historical high
vs 5Y Ago
16x
Strong expansion
Streak
1 yr
Consecutive growthStrong
PeriodValueYoY Change
TTM$47.73M-
2024$0.00-
2023$0.00-
2022$0.00-
2021$0.00-100.0%
2020$2.98M+8.0%
2019$2.76M-